|
|
|
07.04.26 - 22:09
|
Madrigal Pharmaceuticals Announces Grants of Inducement Awards under Nasdaq Listing Rule 5635(c)(4) (GlobeNewswire EN)
|
|
|
CONSHOHOCKEN, Pa., April 07, 2026 (GLOBE NEWSWIRE) -- Madrigal Pharmaceuticals, Inc. (NASDAQ:MDGL), a biopharmaceutical company focused on delivering novel therapeutics for metabolic dysfunction-associated steatohepatitis (MASH), today announced that it granted equity awards on April 1, 2026 to 20 new non-executive employees as equity inducement awards under the terms of Madrigal's 2025 Inducement Plan. The equity awards were approved by Madrigal's independent Compensation Committee in accordance with Nasdaq Listing Rule 5635(c)(4)....
|
|
|
06.04.26 - 22:18
|
Tapestry, Inc. Appoints Matt Madrigal to Board of Directors (Business Wire)
|
|
|
NEW YORK--(BUSINESS WIRE)--Tapestry, Inc. (NYSE: TPR), a house of iconic accessories and lifestyle brands, today announced that Matt Madrigal, Chief Technology Officer of Pinterest, Inc. (NYSE: PINS), has been appointed to the Company's Board of Directors effective immediately. The appointment of Mr. Madrigal brings the Board's membership to eleven, including ten independent directors.
“We are pleased to welcome Matt to Tapestry's Board. His expertise across technology and customer experience at scale will be instrumental in driving our Amplify growth agenda,” said Joanne Crevoiserat, Chief Executive Officer of Tapestry, Inc. “I look forward to partnering with him as we continue to build emotional connections with the next generation of consumers around the world and deliver durable, compounding growth.”
Anne Gates, Chair of the Board of Tapestry, Inc., added, “Matt's deep technical expertise and proven track record of scaling global consumer platforms will bring valuable perspective to the ...
|
|
|
|
|
27.03.26 - 08:45
|
Madrigal Pharmaceuticals-Aktie +12%: Kommt′s zur Übernahme? (Sharedeals)
|
|
|
Die Aktie des US-Pharmaunternehmens Madrigal Pharmaceuticals hat einen kräftigen Kurssprung verzeichnet, nachdem Spekulationen über eine mögliche Übernahme durch den Pharmariesen Eli Lilly aufkamen. Die Anteilsscheine legten im Handel um rund 12 Prozent zu und markierten damit den stärksten Tagesgewinn seit etwa einem Monat. Auslöser der Bewegung war ein Bericht des Marktspekulationsblogs Betaville, der Madrigal als […]
The post Madrigal Pharmaceuticals-Aktie +12%: Kommt's zur Übernahme? first appeared on sharedeals.de....
|
|
|
|
|
19.03.26 - 21:09
|
Madrigal Pharmaceuticals Announces Grants of Inducement Awards under Nasdaq Listing Rule 5635(c)(4) (GlobeNewswire EN)
|
|
|
CONSHOHOCKEN, Pa., March 19, 2026 (GLOBE NEWSWIRE) -- Madrigal Pharmaceuticals, Inc. (NASDAQ:MDGL), a biopharmaceutical company focused on delivering novel therapeutics for metabolic dysfunction-associated steatohepatitis (MASH), today announced that it granted equity awards on March 15, 2026 to seven new non-executive employees as equity inducement awards under the terms of Madrigal's 2025 Inducement Plan. The equity awards were approved by Madrigal's independent Compensation Committee in accordance with Nasdaq Listing Rule 5635(c)(4)....
|
|
|
|
|
|
|
|
|
|
|
|
|
05.03.26 - 22:09
|
Madrigal Pharmaceuticals Announces Grants of Inducement Awards under Nasdaq Listing Rule 5635(c)(4) (GlobeNewswire EN)
|
|
|
CONSHOHOCKEN, Pa., March 05, 2026 (GLOBE NEWSWIRE) -- Madrigal Pharmaceuticals, Inc. (NASDAQ:MDGL), a biopharmaceutical company focused on delivering novel therapeutics for metabolic dysfunction-associated steatohepatitis (MASH), today announced that it granted equity awards on March 1, 2026 to 20 new non-executive employees as equity inducement awards under the terms of Madrigal's 2025 Inducement Plan. The equity awards were approved by Madrigal's independent Compensation Committee in accordance with Nasdaq Listing Rule 5635(c)(4)....
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Börsentreff auf Facebook |
Börsentreff auf X |
Börsentreff auf Instagram
